Journal article
Management of Chronic Symptoms of Lyme Disease With Intravenous Ceftriaxone
CUREUS JOURNAL OF MEDICAL SCIENCE, v 13(7), e16354
13 Jul 2021
PMID: 34395132
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Lyme disease is a vector-borne illness of North America and Europe transmitted by Borrelia burgdorferi, over 30,000 cases are reported in the United States yearly. Patients typically present having early localized disease with fevers, headaches, myalgias, and a single erythema migrans. Usually, oral doxycycline is administered with a good disease prognosis but we report the case of a 58-year-old male who presented with Lyme disease diagnosed by immunoassay; he was treated with doxycycline but was refractory and saw an improvement in his symptoms with IV ceftriaxone.
Metrics
3 Record Views
Details
- Title
- Management of Chronic Symptoms of Lyme Disease With Intravenous Ceftriaxone
- Publication Details
- CUREUS JOURNAL OF MEDICAL SCIENCE, v 13(7), e16354
- Publisher
- SPRINGERNATURE; LONDON
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Drexel University
- Web of Science ID
- WOS:000675634000006
- Other Identifier
- 991021860655304721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Immunology